↓ Skip to main content

Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis

Overview of attention for article published in Frontiers in immunology, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
13 X users

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis
Published in
Frontiers in immunology, August 2019
DOI 10.3389/fimmu.2019.02021
Pubmed ID
Authors

Toru Kato, Koubun Yasuda, Kazufumi Matsushita, Ken J. Ishii, Seiichi Hirota, Tomohiro Yoshimoto, Hiroaki Shibahara

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 18%
Student > Bachelor 7 14%
Other 5 10%
Researcher 5 10%
Student > Postgraduate 4 8%
Other 6 12%
Unknown 13 27%
Readers by discipline Count As %
Medicine and Dentistry 9 18%
Biochemistry, Genetics and Molecular Biology 8 16%
Immunology and Microbiology 7 14%
Neuroscience 3 6%
Veterinary Science and Veterinary Medicine 2 4%
Other 4 8%
Unknown 16 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2023.
All research outputs
#2,312,227
of 25,774,185 outputs
Outputs from Frontiers in immunology
#2,282
of 32,357 outputs
Outputs of similar age
#46,083
of 353,059 outputs
Outputs of similar age from Frontiers in immunology
#75
of 702 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,357 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,059 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 702 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.